Pharmaceutical Solutions Provider - Skila Expands Global Partnership
with Boehringer Ingelheim
Morris Plains, N.J.,
July 27, 2006 - Skila, a Sela2 Company, has expanded its existing
partnership with Boehringer Ingelheim GmbH to provide knowledge management
solutions to support the pharmaceutical company's Global Brand Effectiveness.
Skila has been a long-standing partner of Boehringer Ingelheim in
providing knowledge management solutions in the areas of launch management,
alliance management, competitive intelligence, performance management,
and thought leader management.
Under the terms of this contract expansion, Boehringer Ingelheim will
implement Skila's comprehensive suite of solutions as its Brand Resource
Platform serving products in various stages across Boehringer Ingelheim's
brand portfolio in prescription medicine and consumer health. With
an installed base extending from Boehringer Ingelheim corporate headquarters
in Ingelheim, Germany, to affiliates in numerous countries worldwide,
Skila's platform will allow Boehringer Ingelheim to improve communication,
increase coordination, and enhance planning and decision-making capabilities
across the global organization.
"The value of Skila's solutions
is exponentially enhanced when integrated on a global scale. We are
pleased to be building upon our partnership with Boehringer Ingelheim
to streamline their marketing process at all levels of their organization,"
said Moish Tov, CEO of Skila.
About Skila
Skila is a global technology and services company specializing in knowledge and effectiveness solutions for the healthcare industry. Skila’s solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams. These solutions include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global Pharmaceutical companies, Skila’s solutions have been deployed in 61 countries, supporting numerous global brands and over 10 million user interactions. Skila’s long-standing commitment and understanding of customers’ needs has resulted in the long-term growth and adoption of our methodology, technology and continuous services as the business platform of choice for many of our clients.
